References
- Bacon K. B., Premack B. A., Gardner P., Schall T. J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995; 269: 1727–1730, [PUBMED], [INFOTRIEVE]
- Bacon K. B., Szabo M. C., Yassel H., Bolen J. B., Schall T. J. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP‐70 in human T cells. J. Exp. Med. 1996; 184: 873–882, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bauch A., Alt F. W., Crabtree G. R., Snapper S. B. The cytoskeleton in lymphocyte signaling. Adv. Immunol. 2000; 75: 89–114, [PUBMED], [INFOTRIEVE], [CSA]
- Brault S. M., Kurt R. A. Chemokines and anti‐tumor immunity: walking the tightrope. Int. Rev. Immunol. 2003; 22: 199–228, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cerami A., Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 1988; 9: 28–31, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chan A. C., Kadlecek T. A., Elder M. E., Filipovich A. H., Kuo W. L., Iwashima M., Parslow T. G., Weiss A. ZAP‐70 deficieny in an autosomal recessive form of severe combined immunodeficiency. Science 1994; 264: 1599–1601, [PUBMED], [INFOTRIEVE]
- Correa M. R., Ochoa A. C., Ghosh P., Mizoguchi H., Harvey L., Longo D. L. Sequential development of structural and functional alterations in T cells from tumor‐bearing mice. J. Immunol. 1997; 158: 5292–5296, [PUBMED], [INFOTRIEVE]
- Dairaghi D. J., Soo K. S., Oldham E. R., Premack B. A., Kitamura T., Bacon K. B., Schall T. J. RANTES‐induced T cell activation correlates with CD3 expression. J. Immunol. 1998; 160: 426–433, [PUBMED], [INFOTRIEVE]
- Dighe A. S., Richards E., Old L. J., Schreiber R. D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1994; 1: 447–456, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fischer K. D., Tedford K., Penninger J. M. Vav links antigen‐receptor signaling to the actin cytoskeleton. Semin. Immunol. 1998; 10: 317–327, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fra A. M., Locati M., Otero K., Sironi M., Signorelli P., Massardi M. L., Gobbi M., Vecchi A., Sozzani S., Mantovani A. Scavenging of inflammatory CC chemokines by promiscuous putatively silent chemokine receptor D6. J. Immunol. 2003; 170: 2279–2282, [PUBMED], [INFOTRIEVE]
- Ghosh P., Sica A., Young H. A., Ye J., Franco J. L., Wiltrout R. H., Longo D. L., Rice N. R., Komschlies K. L. Alterations in NFkB/Rel family proteins in splenic T‐cells from tumor‐bearing mice and reversal following therapy. Cancer Res. 1994; 54: 2969–2972, [PUBMED], [INFOTRIEVE]
- Guinamard R., Signoret N., Masamichi I., Marsh M., Kurosaki T., Ravetch J. V. B cell antigen receptor engagement inhibits stromal cell‐derived factor (SDF)‐1a chemotaxis and promotes protein kinase C (PKC)‐induced internalization of CXCR4. J. Exp. Med. 1999; 189: 1461–1466, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jung S., Littman D. R. Chemokine receptors in lymphoid organ homeostasis. Curr. Opin. Immunol. 1999; 11: 319–325, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaplan D. H., Shankaran V., Dighe A. S., Stockert E., Aguet M., Old L. J., Schreiber R. D. Demonstration of an interferon gamma‐dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7556–7561, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Krakeuer T. Immune response to staphylococcal superantigens. Immunol. Res. 1999; 20: 163–173, [CSA]
- Kranewitter W. J., Danninger C., Gimona M. GEF at work: vav in protruding filopodia. Cell Motil. Cytoskelet. 2001; 49: 154–160, [CROSSREF], [CSA]
- Kurt R. A., Baher A., Wisner K. P., Tackitt S., Urba W. J. Chemokine receptor desensitization in tumor‐bearing mice. Cell. Immunol. 2001; 207: 81–88, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lu B., Rutledge B. J., Gu L., Fiorillo J., Lukacs N. W., Kunkel S. L., North R., Gerard C., Rollins B. J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1‐deficient mice. J. Exp. Med. 1998; 187: 601–608, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Luboshits G., Shina S., Kaplan O., Engelberg S., Nass D., Lifshitz‐Mercer B., Chaitchik S., Keydar I., Ben‐Barcuh A. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast cancer. Cancer Res. 1999; 59: 4681–4687, [PUBMED], [INFOTRIEVE]
- Mashikian M. V., Ryan T. C., Seman A., Brazer W., Center D. M., Cruikshank W. W. Reciprocal desensitization of CCR5 and CD4 is mediated by IL‐16 and macrophage‐inflammatory protein‐1β, respectively. J. Immunol. 1999; 163: 3123–3130, [PUBMED], [INFOTRIEVE]
- Niwa Y., Akamatsu H., Niwa H., Sumi H., Ozaki Y., Abe A. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin. Cancer Res. 2001; 7: 285–289, [PUBMED], [INFOTRIEVE], [CSA]
- Peacock J. W., Jirik F. R. TCR activation inhibits chemotaxis toward stromal cell‐derived factor‐1: evidence for reciprocal regulation between CXCR4 and the TCR. J. Immunol. 1999; 162: 215–223, [PUBMED], [INFOTRIEVE]
- Peng L., Shu S., Krauss J. C. Monocyte chemoattractant protein inhibits the generation of tumor‐reactive T cells. Cancer Res. 1997; 57: 4849–4854, [PUBMED], [INFOTRIEVE]
- Radoja S., Saio M., Schaer D., Koneru M., Vukmanovic S., Frey A. B. CD8 + tumor‐infiltrating T cells are deficient in perforin‐mediated cytolytic activity due to defective microtubule‐organizing center mobilization and lytic granule exocytosis. J. Immunol. 2001; 167: 5042–5051, [PUBMED], [INFOTRIEVE]
- Riffo‐Vasquez Y., Spina D. Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation. Pharmacol. Ther. 2002; 94: 185–211, [CROSSREF], [CSA]
- Sanzenbacher R., Kabelitz D., Janssen O. SLP‐76 binding to p56lck: a role for SLP‐76 in CD4‐induced desensitization of the TCR/CD3 signaling complex. J. Immunol. 1999; 163: 3143–3152, [PUBMED], [INFOTRIEVE]
- Shu S., Krinock R. A., Matsumura T., Sussman J. J., Fox B. A., Chang A. E., Terman D. S. Stimulation of tumor‐draining lymph node cells with superantigen staphylococcal toxins leads to the generation of tumor‐specific effector T cells. J. Immunol. 1994; 152: 1277–1285, [PUBMED], [INFOTRIEVE]
- Su S. B., Gong W., Grimm M., Utsunomiya I., Sargeant R., Oppenheim J. J., Ming W. J. Inhibition of tyrosine kinase activation blocks the down‐regulation of CXC chemokine receptor 4 by HIV‐1 gp120 in CD4 + T cells. J. Immunol. 1999; 162: 7128–7132, [PUBMED], [INFOTRIEVE]
- Szekabecz Z., Kim J., Koch A. E. Chemokines and chemokine receptors in rheumatoid arthritis. Semin. Immunol. 2003; 15: 15–21, [CROSSREF], [CSA]
- Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., Koike M., Inadera H., Matsushima K. Significance of macrophage chemoattractant protein‐1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 2000; 6: 3282–3289, [PUBMED], [INFOTRIEVE], [CSA]